Literature DB >> 25085522

Congenital eyelid ptosis: onset and prevalence of amblyopia, associations with systemic disorders, and treatment outcomes.

August Stein1, John P Kelly1, Avery H Weiss2.   

Abstract

OBJECTIVES: To determine the age at onset of amblyopia, the response to occlusion therapy, and the association with systemic disorders in children with congenital eyelid ptosis. STUDY
DESIGN: Retrospective chart review of children seen at Seattle Children's Hospital with moderate or severe congenital ptosis. Assessments were longitudinal visual acuity development using objective methods, definition of ptosis severity by eyelid margin to pupillary light reflex distance (margin reflex distance [MRD]), age at amblyopia diagnosis, correlation between amblyopia and MRD, and associated systemic disorders.
RESULTS: Eighty-four children with moderate-to-severe congenital ptosis met inclusion criteria; the mean longitudinal follow-up was 49.1 months. Fifteen (18%) of these children had amblyopia, of which 9 had deprivation amblyopia (mean age 17.3 months ± 11.2) and 6 had anisometropic or strabismic amblyopia (mean age 60 months ± 11.8). Eleven (73%) of the children with amblyopia were successfully treated with occlusion therapy. Amblyopia was not correlated with MRD. A systemic disorder was identified in 29 (35%) of the children, the most common being genetic, chromosomal, or neurologic conditions. Patients with systemic disorders and developmental delay have significantly lower visual acuity bilaterally compared with patients without systemic disorders (P ≤ .003).
CONCLUSIONS: Using longitudinal and objective visual acuity assessments, the incidence of amblyopia was 18% in children with moderate to severe congenital ptosis. Visual deprivation was the predominant risk factor that was reliably distinguished by its earlier onset in young children. The best indicator of amblyopia in children is visual acuity rather than MRD measurements. Systemic disorders are frequent in children with moderate to severe congenital ptosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25085522     DOI: 10.1016/j.jpeds.2014.06.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  [Current aspects of eyelid, lacrimal and orbital surgery in childhood].

Authors:  G Avgitidou; K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

2.  Modified levator muscle complex suspension on treating pediatric blepharoptosis with poor Bell's phenomenon.

Authors:  Rui Li; Xiao-Wei Zhu; Jia-Ying Zhang; Xia Ding; Xu-Sheng Wu; Yue Xing; Ming Lin; Jin Li
Journal:  Int Ophthalmol       Date:  2022-05-27       Impact factor: 2.029

3.  The Prevalence of Ptosis and Nystagmus in Rural Population.

Authors:  Hassan Hashemi; Leila Molaei; Abbasali Yekta; Mohammadreza Aghamirsalim; Hadi Ostadimoghaddam; Frida Jabbari-Azad; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2020-04-30

4.  Refractive error characteristics in patients with congenital blepharoptosis before and after ptosis repair surgery.

Authors:  Ji-Sun Paik; Su-Ah Kim; Shin Hae Park; Suk-Woo Yang
Journal:  BMC Ophthalmol       Date:  2016-10-08       Impact factor: 2.209

Review 5.  Clinical presentation and management of congenital ptosis.

Authors:  Marco Marenco; Ilaria Macchi; Iacopo Macchi; Emilio Galassi; Mina Massaro-Giordano; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2017-02-27

6.  Amblyopia, Strabismus and Refractive Errors in Congenital Ptosis: a systematic review and meta-analysis.

Authors:  Yijie Wang; Yufeng Xu; Xi Liu; Lixia Lou; Juan Ye
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

7.  The prevalence of ptosis in an Iranian adult population.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Mohammad Hassan Emamian; Abbasali Yekta; Ali Jafari; Payam Nabovati; Akbar Fotouhi
Journal:  J Curr Ophthalmol       Date:  2016-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.